دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
New Order, New Hope
Andrew L. Tambyraja, M.D.
doi : 10.1056/NEJMp2016142
N Engl J Med 2020; 383:2495-2496
Sewing Masks — Resilience in the Face of Covid
Eve Rittenberg, M.D.
doi : 10.1056/NEJMp2019830
N Engl J Med 2020; 383:2497-2498
Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson’s Disease
Ra?l Mart?nez-Fern?ndez, M.D., Ph.D., Jorge U. M??ez-Mir?, M.D., Rafael Rodr?guez-Rojas, Ph.D., Marta del ?lamo, M.D., Binit B. Shah, M.D., Frida Hern?ndez-Fern?ndez, M.Sc., José A. Pineda-Pardo, Ph.D., Mariana H.G. Monje, M.D., Ph.D., Beatriz Fern?ndez-Rodr?guez, M.D., Scott A. Sperling, Psy.D., David Mata-Mar?n, M.Sc., Pasqualina Guida, M.Sc.,
doi : 10.1056/NEJMoa2016311
N Engl J Med 2020; 383:2501-2513
The subthalamic nucleus is the preferred neurosurgical target for deep-brain stimulation to treat cardinal motor features of Parkinson’s disease. Focused ultrasound is an imaging-guided method for creating therapeutic lesions in deep-brain structures, including the subthalamic nucleus.
Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries
The WHO ACTION Trials Collaborators
doi : 10.1056/NEJMoa2022398
N Engl J Med 2020; 383:2514-2525
The safety and efficacy of antenatal glucocorticoids in women in low-resource countries who are at risk for preterm birth are uncertain.
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
Andrew H. Wei, M.B., B.S., Ph.D., Hartmut D?hner, M.D., Christopher Pocock, M.B., B.S., Pau Montesinos, M.D., Ph.D., Boris Afanasyev, M.D., D.Sci., Hervé Dombret, M.D., Farhad Ravandi, M.D., Hamid Sayar, M.D., Jun-Ho Jang, M.D., Ph.D., Kimmo Porkka, M.D., Dominik Selleslag, M.D., Irwindeep Sandhu, M.D.,
doi : 10.1056/NEJMoa2004444
N Engl J Med 2020; 383:2526-2537
Although induction chemotherapy results in remission in many older patients with acute myeloid leukemia (AML), relapse is common and overall survival is poor.
Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease
Joakim Nordanstig, M.D., Ph.D., Stefan James, M.D., Ph.D., Manne Andersson, M.D., Ph.D., Mattias Andersson, M.D., Peter Danielsson, M.D., Ph.D., Peter Gillgren, M.D., Ph.D., Martin Delle, M.D., Ph.D., Jan Engstr?m, M.D., Torbj?rn Fransson, M.D., Maher Hamoud, M.D., Ph.D., Anna Hilbertson, M.D., Patrik Johansson, M.D.,
doi : 10.1056/NEJMoa2005206
N Engl J Med 2020; 383:2538-2546
The results of a recent meta-analysis aroused concern about an increased risk of death associated with the use of paclitaxel-coated angioplasty balloons and stents in lower-limb endovascular interventions for symptomatic peripheral artery disease.
Changes in Seizure Frequency and Antiepileptic Therapy during Pregnancy
Page B. Pennell, M.D., Jacqueline A. French, M.D., Ryan C. May, Ph.D., Elizabeth Gerard, M.D., Laura Kalayjian, M.D., Patricia Penovich, M.D., Evan Gedzelman, M.D., Jennifer Cavitt, M.D., Sean Hwang, M.D., Alison M. Pack, M.D., Maria Sam, M.D., John W. Miller, M.D., Ph.D.,
doi : 10.1056/NEJMoa2008663
N Engl J Med 2020; 383:2547-2556
Among women with epilepsy, studies regarding changes in seizure frequency during pregnancy have been limited by the lack of an appropriate nonpregnant comparator group to provide data on the natural course of seizure frequency in both groups.
Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer
Harold J. Burstein, M.D., Ph.D.
doi : 10.1056/NEJMra1307118
N Engl J Med 2020; 383:2557-2570
Hemophagocytosis of Sickle Cells
Felix Mensah, M.D., and Monica Pilichowska, M.D., Ph.D.
doi : 10.1056/NEJMicm2021493
N Engl J Med 2020; 383:2571
Hearing Music while Checking a Pulse
Leanna Wise, M.D.
doi : 10.1056/NEJMicm1911324
N Engl J Med 2020; 383:e139
Case 40-2020: A 24-Year-Old Man with Headache and Covid-19
Howard M. Heller, M.D., M.P.H., R. Gilberto Gonzalez, M.D., Brian L. Edlow, M.D., Kevin L. Ard, M.D., M.P.H., and Tasos Gogakos, M.D., Ph.D.
doi : 10.1056/NEJMcpc2027083
N Engl J Med 2020; 383:2572-2580
Parkinson’s Disease — What’s the FUS?
Joel S. Perlmutter, M.D., and Mwiza Ushe, M.D.
doi : 10.1056/NEJMe2031151
N Engl J Med 2020; 383:2582-2584
Antenatal Glucocorticoids in Low-Resource Settings — Who, When, and Where?
Dwight J. Rouse, M.D., and Jeffrey S.A. Stringer, M.D.
doi : 10.1056/NEJMe2032499
N Engl J Med 2020; 383:2584-2585
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
doi : 10.1056/NEJMc2031670
N Engl J Med 2020; 383:2586-2588
